市場調查報告書
商品編碼
1518905
全球遠端患者監護(RPM) 產業透過策略合作夥伴關係推動變革性成長:預測,2024-2028 年Remote Patient Monitoring Sector Driving Transformational Growth through Strategic Partnerships: Forecast-Global, 2024-2028 |
產業融合數位化加劇競爭環境
遠端患者監護(RPM) 包括旨在允許臨床醫生遠端收集和監測患者生物識別資料和行為的設備和IT基礎設施。該基礎設施包括軟體、閘道器、平台、資料傳輸和管理系統、網路等。雖然智慧型手機、智慧型手錶和健身追蹤器等消費者穿戴式裝置可以提供類似的資料(例如心率、睡眠品質、行動性),但本研究僅關注 RPM 技術
這項全球分析概述了主要市場,重點關注美國,該地區的高資料可用性正在推動該地區Start-Ups的顯著成長和創新。 RPM 產業根據持續關注以及產品和服務提供範圍進行細分。公司可能會為特定照護端提供一系列產品,也可能專門為更廣泛的用途提供產品和服務。儘管這些產品之間存在差異,但 Frost & Sullivan 並未提供任何有關產品細分的預測,因為該行業主要將這些產品和服務作為捆綁解決方案進行銷售。
這種全面的分析為醫療保健相關人員提供了重要的見解,以應對不斷變化的 RPM 格局,揭示對策略決策至關重要的成長機會、區域趨勢和經營模式分析。
Industry Convergence and Digitalization Intensify the Competitive Environment
Remote patient monitoring (RPM) encompasses devices and IT infrastructure designed to enable clinicians to collect and monitor patients' biometric data and behaviors remotely. This infrastructure includes software, gateways, platforms, data transmission and management systems, and networks. While consumer-grade wearables, including smartphones, smartwatches, and fitness trackers, can provide similar data (e.g., heart rate, sleep quality, mobility), this study focuses exclusively on clinician-intended RPM technologies due to their higher consistency and accuracy.
RPM differs from telehealth, which primarily involves communication via video or audio between patients and clinicians. Instead, RPM focuses on the remote collection of vital statistics, biochemistry, and cardiac rhythms, along with related products and services that transmit and provide clinical insights into the collected data. Despite the integral role of EMR/EHR technology in RPM workflows, this study excludes these technologies from market calculations, treating them as separate entities.
Many consumer-grade wearables (e.g., smartphones, smartwatches, and fitness trackers) provide data similar to devices that are part of the RPM industry (e.g., heart rate and rhythm, sleep length and quality, and mobility). However, for this analysis, we limit the definition of RPM to technologies specifically intended for use by clinicians to monitor patients. While it is possible to use consumer-grade devices in medical RPM in the future, there is a wider variance in their consistency and accuracy, so clinicians do not currently widely accept them.
This global analysis provides an overview of major markets, primarily the United States due to the greater availability of data and significant growth and innovation driven by start-ups in the region. The RPM industry is segmented by care continuum and the range of products and services offered. Companies may offer a suite of products for specific points of care or specialize in products or services with broader applications. While the differentiation among these offerings is noted, Frost & Sullivan does not provide forecasts on product segmentation, as the industry predominantly sells these products and services as bundled solutions.
The comprehensive analysis equips healthcare stakeholders with critical insights to navigate the evolving RPM landscape, highlighting growth opportunities, regional trends, and business model analyses essential for strategic decision-making.